Episode 121: Home Infusion of Antineoplastics During COVID-19

Lisa Kennedy-Sheldon, PhD, ANP-BC, AOCNP®, FAAN, ONS clinical and scientific affairs liaison, joins Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS®, ONS oncology clinical specialist and former home care nurse, to discuss how the COVID-19 coronavirus pandemic affects antineoplastics administration and safety considerations for in-home cancer care. More information is available in ONS's recent position statement, linked in the episode notes. This episode is supported by an educational grant from Genentech, a member of the Roche Group. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Episode Notes Check out these resources from today's episode: The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.  ONS position statement: Infusion of Antineoplastic Therapies in the Home  Oncology Nursing Podcast Episode 53: Home Care Nursing for Patients With Cancer  Oncology Nursing Podcast Episode 96: The COVID-19 Coronavirus and Cancer Care  Oncology Nursing Podcast Episode 97: COVID-19 Cancer Care Lessons From Seattle and New York  ONS Voice article: Home Care for Patients With Cancer  ONS Recommendations for Oncology Staff Assignments During the COVID-19 Pandemic  ONS Interim PPE Guidelines During the COVID-19 Pandemic  ASCO/ONS Chemotherapy Administration Safety Standards  American Association of Cancer Research meeting: COVID-19 and Cancer